(3S,8S,9S,10R,13R,14R,17R)-17-[(E,1R,4S)-4-ethyl-1,5-dimethyl-hex-2-enyl]-8,10,13-trimethyl-1,2,3,4,7,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-ol

Details

Top
Internal ID b5fc7cd4-a3dd-4f72-ae93-64ec8b7c89f9
Taxonomy Lipids and lipid-like molecules > Steroids and steroid derivatives > Stigmastanes and derivatives
IUPAC Name (3S,8S,9S,10R,13R,14R,17R)-17-[(E,2R,5S)-5-ethyl-6-methylhept-3-en-2-yl]-8,10,13-trimethyl-1,2,3,4,7,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-ol
SMILES (Canonical) CCC(C=CC(C)C1CCC2C1(CCC3C2(CC=C4C3(CCC(C4)O)C)C)C)C(C)C
SMILES (Isomeric) CC[C@H](/C=C/[C@@H](C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@]2(CC=C4[C@@]3(CC[C@@H](C4)O)C)C)C)C(C)C
InChI InChI=1S/C30H50O/c1-8-22(20(2)3)10-9-21(4)25-11-12-26-29(25,6)18-15-27-28(5)17-14-24(31)19-23(28)13-16-30(26,27)7/h9-10,13,20-22,24-27,31H,8,11-12,14-19H2,1-7H3/b10-9+/t21-,22-,24+,25-,26-,27-,28+,29-,30+/m1/s1
InChI Key HDJHBDFXQMIPJD-GXRZYGKRSA-N
Popularity 1 reference in papers

Physical and Chemical Properties

Top
Molecular Formula C30H50O
Molecular Weight 426.70 g/mol
Exact Mass 426.386166214 g/mol
Topological Polar Surface Area (TPSA) 20.20 Ų
XlogP 9.00
Atomic LogP (AlogP) 8.19
H-Bond Acceptor 1
H-Bond Donor 1
Rotatable Bonds 5

Synonyms

Top
There are no found synonyms.

2D Structure

Top
2D Structure of (3S,8S,9S,10R,13R,14R,17R)-17-[(E,1R,4S)-4-ethyl-1,5-dimethyl-hex-2-enyl]-8,10,13-trimethyl-1,2,3,4,7,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-ol

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 1.0000 100.00%
Caco-2 - 0.5197 51.97%
Blood Brain Barrier + 0.5750 57.50%
Human oral bioavailability - 0.6000 60.00%
Subcellular localzation Lysosomes 0.4691 46.91%
OATP2B1 inhibitior - 1.0000 100.00%
OATP1B1 inhibitior + 0.8190 81.90%
OATP1B3 inhibitior + 0.9820 98.20%
MATE1 inhibitior - 1.0000 100.00%
OCT2 inhibitior - 0.8750 87.50%
BSEP inhibitior + 0.9069 90.69%
P-glycoprotein inhibitior + 0.5776 57.76%
P-glycoprotein substrate + 0.5257 52.57%
CYP3A4 substrate + 0.6484 64.84%
CYP2C9 substrate - 0.6197 61.97%
CYP2D6 substrate - 0.7147 71.47%
CYP3A4 inhibition - 0.8309 83.09%
CYP2C9 inhibition - 0.9125 91.25%
CYP2C19 inhibition - 0.9025 90.25%
CYP2D6 inhibition - 0.9346 93.46%
CYP1A2 inhibition - 0.9291 92.91%
CYP2C8 inhibition + 0.4551 45.51%
CYP inhibitory promiscuity - 0.5244 52.44%
UGT catelyzed + 0.7000 70.00%
Carcinogenicity (binary) - 0.9700 97.00%
Carcinogenicity (trinary) Non-required 0.5888 58.88%
Eye corrosion - 0.9886 98.86%
Eye irritation - 0.9603 96.03%
Skin irritation + 0.5270 52.70%
Skin corrosion - 0.9561 95.61%
Ames mutagenesis - 0.6778 67.78%
Human Ether-a-go-go-Related Gene inhibition + 0.6666 66.66%
Micronuclear - 0.9600 96.00%
Hepatotoxicity - 0.5833 58.33%
skin sensitisation + 0.6416 64.16%
Respiratory toxicity + 0.7000 70.00%
Reproductive toxicity + 0.9111 91.11%
Mitochondrial toxicity + 0.9125 91.25%
Nephrotoxicity - 0.8443 84.43%
Acute Oral Toxicity (c) I 0.4287 42.87%
Estrogen receptor binding + 0.8462 84.62%
Androgen receptor binding + 0.6783 67.83%
Thyroid receptor binding + 0.6260 62.60%
Glucocorticoid receptor binding + 0.8145 81.45%
Aromatase binding - 0.4915 49.15%
PPAR gamma + 0.6094 60.94%
Honey bee toxicity - 0.8023 80.23%
Biodegradation - 0.8000 80.00%
Crustacea aquatic toxicity - 0.5300 53.00%
Fish aquatic toxicity + 0.9917 99.17%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL3251 P19838 Nuclear factor NF-kappa-B p105 subunit 97.80% 96.09%
CHEMBL253 P34972 Cannabinoid CB2 receptor 97.32% 97.25%
CHEMBL2581 P07339 Cathepsin D 96.90% 98.95%
CHEMBL226 P30542 Adenosine A1 receptor 95.75% 95.93%
CHEMBL221 P23219 Cyclooxygenase-1 94.25% 90.17%
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 92.84% 91.11%
CHEMBL3137262 O60341 LSD1/CoREST complex 88.73% 97.09%
CHEMBL1977 P11473 Vitamin D receptor 86.63% 99.43%
CHEMBL4203 Q9HAZ1 Dual specificity protein kinase CLK4 85.28% 94.45%
CHEMBL3359 P21462 Formyl peptide receptor 1 84.71% 93.56%
CHEMBL4227 P25090 Lipoxin A4 receptor 84.70% 100.00%
CHEMBL5608 Q16288 NT-3 growth factor receptor 84.31% 95.89%
CHEMBL1994 P08235 Mineralocorticoid receptor 84.25% 100.00%
CHEMBL4051 P13569 Cystic fibrosis transmembrane conductance regulator 84.17% 95.71%
CHEMBL5845 P23415 Glycine receptor subunit alpha-1 83.64% 90.71%
CHEMBL299 P17252 Protein kinase C alpha 81.81% 98.03%
CHEMBL4224 P49759 Dual specificty protein kinase CLK1 81.62% 85.30%
CHEMBL3108638 O15164 Transcription intermediary factor 1-alpha 80.78% 95.56%
CHEMBL1806 P11388 DNA topoisomerase II alpha 80.59% 89.00%
CHEMBL2959 Q08881 Tyrosine-protein kinase ITK/TSK 80.03% 95.00%

Cross-Links

Top
PubChem 23246947
NPASS NPC29280
LOTUS LTS0254062
wikiData Q105026382